228 related articles for article (PubMed ID: 28400960)
1. Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice.
Ruscitti F; Ravanetti F; Essers J; Ridwan Y; Belenkov S; Vos W; Ferreira F; KleinJan A; van Heijningen P; Van Holsbeke C; Cacchioli A; Villetti G; Stellari FF
Multidiscip Respir Med; 2017; 12():8. PubMed ID: 28400960
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
3. A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin.
Yang X; Huang XJ; Chen Z; Xu AL; Zhou H; Bi XL; Yan PY; Xie Y
Heliyon; 2023 Mar; 9(3):e13598. PubMed ID: 36895392
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rosiglitazone on bleomycin-induced lung fibrosis: Assessed by micro-computed tomography and pathologic scores.
Jin GY; Bok SM; Han YM; Chung MJ; Yoon KH; Kim SR; Lee YC
Eur J Radiol; 2012 Aug; 81(8):1901-6. PubMed ID: 21296518
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of lung TRPV1/TRPA1 in a cough model of bleomycin-induced pulmonary fibrosis in Guinea pigs.
Guo Y; Ying S; Zhao X; Liu J; Wang Y
BMC Pulm Med; 2019 Feb; 19(1):27. PubMed ID: 30717786
[TBL] [Abstract][Full Text] [Related]
6. A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice.
Ruscitti F; Ravanetti F; Donofrio G; Ridwan Y; van Heijningen P; Essers J; Villetti G; Cacchioli A; Vos W; Stellari FF
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708527
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
Vande Velde G; Poelmans J; De Langhe E; Hillen A; Vanoirbeek J; Himmelreich U; Lories RJ
Dis Model Mech; 2016 Jan; 9(1):91-8. PubMed ID: 26563390
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo micro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation.
Scotton CJ; Hayes B; Alexander R; Datta A; Forty EJ; Mercer PF; Blanchard A; Chambers RC
Eur Respir J; 2013 Dec; 42(6):1633-45. PubMed ID: 23520313
[TBL] [Abstract][Full Text] [Related]
9. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
He F; Zhou A; Feng S
PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
[TBL] [Abstract][Full Text] [Related]
10. Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography.
De Langhe E; Vande Velde G; Hostens J; Himmelreich U; Nemery B; Luyten FP; Vanoirbeek J; Lories RJ
PLoS One; 2012; 7(8):e43123. PubMed ID: 22912805
[TBL] [Abstract][Full Text] [Related]
11. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography.
Cavanaugh D; Travis EL; Price RE; Gladish G; White RA; Wang M; Cody DD
Acad Radiol; 2006 Dec; 13(12):1505-12. PubMed ID: 17138119
[TBL] [Abstract][Full Text] [Related]
12. Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography.
Ruscitti F; Ravanetti F; Bertani V; Ragionieri L; Mecozzi L; Sverzellati N; Silva M; Ruffini L; Menozzi V; Civelli M; Villetti G; Stellari FF
Front Pharmacol; 2020; 11():1117. PubMed ID: 32792953
[TBL] [Abstract][Full Text] [Related]
13. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S
J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989
[TBL] [Abstract][Full Text] [Related]
14. [Effect of water-soluble C(60) fullerenes on pulmonary fibrosis induced by bleomycin in mice].
Dong R; Liu M; Huang XX; Liu Z; Jiang DY; Xiao HJ; Dai HP
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(22):1740-1744. PubMed ID: 28606286
[No Abstract] [Full Text] [Related]
15. A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury.
Shofer S; Badea C; Qi Y; Potts E; Foster WM; Johnson GA
J Appl Physiol (1985); 2008 Aug; 105(2):669-77. PubMed ID: 18566189
[TBL] [Abstract][Full Text] [Related]
16. Low-dose administration of bleomycin leads to early alterations in lung mechanics.
Headley L; Bi W; Wilson C; Collum SD; Chavez M; Darwiche T; Mertens TCJ; Hernandez AM; Siddiqui SR; Rosenbaum S; Johnston RA; Karmouty-Quintana H
Exp Physiol; 2018 Dec; 103(12):1692-1703. PubMed ID: 30260066
[TBL] [Abstract][Full Text] [Related]
17. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
18. Standardized quantification of pulmonary fibrosis in histological samples.
Hübner RH; Gitter W; El Mokhtari NE; Mathiak M; Both M; Bolte H; Freitag-Wolf S; Bewig B
Biotechniques; 2008 Apr; 44(4):507-11, 514-7. PubMed ID: 18476815
[TBL] [Abstract][Full Text] [Related]
19. Serial micro-CT assessment of the therapeutic effects of rosiglitazone in a bleomycin-induced lung fibrosis mouse model.
Choi EJ; Jin GY; Bok SM; Han YM; Lee YS; Jung MJ; Kwon KS
Korean J Radiol; 2014; 15(4):448-55. PubMed ID: 25053904
[TBL] [Abstract][Full Text] [Related]
20. Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.
Lee HJ; Goo JM; Kim NR; Kim MA; Chung DH; Son KR; Kim HC; Lee CH; Park CM; Chun EJ; Im JG
Invest Radiol; 2008 Jun; 43(6):453-60. PubMed ID: 18496052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
